 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/449913
Translational Medicine - Drug Development Transformed? (Market Focus)
|
Description: |
A paradigm shift is emerging in the pharmaceutical industry that will change drug discovery and development. The shift towards translational medicine will largely depend on the ability of technology vendors to offer solutions to both the cultural and technology issues surrounding translational research.
Scope of this title: Geographic coverage includes the US, Canada and Western Europe Builds on ongoing primary research with pharmaceutical companies, technology vendors, physicians, consumers and healthcare organizations
Highlights of this title: Translational medicine is real and fueled by healthcare trends, such as consumerism and personalized care Existing business models are called into question, driving translational medicine Both cultural and technology barriers slow the progress of translational medicine
Reasons to order your copy: Identify and evaluate factors that will affect translational medicine in the pharmaceutical industry Understand the market factors driving technology adoption by pharmaceutical companies Align your strategy with developments in the pharmaceutical industry
|
|
Contents: |
OUR VIEW 1 CATALYST 1 SUMMARY 1 METHODOLOGY 1 ANALYSIS 2 Translational medicine is real and fueled by patient-centered care 2 Defining translational medicine 2 The pharmaceutical industry mirrors healthcare trends 3 Existing business models are called into question, driving translational medicine 4 A deepening research & development crisis is driving the adoption of alternative business models 5 Demographic shifts will overburden existing health systems 6 Threat by low-cost generic drugs is changing the industrys focus towards high value products 7 Private and public industry initiatives indicate translational medicine is gaining momentum 7 Both cultural and technology barriers slow the progress of translational medicine 8 Translational medicine challenges the traditional culture of drug development 8 Translational medicine requires a level of technology infrastructure that transcends the lab 9 A lack of urgency by some companies will slow the overall adoption of translational medicine 9 Data analytics will catalyze translational medicine and connect it to patient-centered care 10 ACTIONS 11 Present technology for translational medicine as part of an existing and familiar solution 11 Position technology as a partner in drug discovery and development 11 Demystify cultural and technology challenges by educating end-users early 12 APPENDIX 13 Definitions 13 Abbreviations 13 External methodology 13 Further reading 14 Our Technology Consultancy 14 Ask the analyst List of Figures Figure 1: Translational medicine vs. traditional drug development 3 Figure 2: As healthcare moves towards patient-centered care, the pharmaceutical industry takes a parallel direction through translational medicine. 4 Figure 3: Despite increased spending on R&D, the pharmaceutical industry is facing a deep productivity crisis. 5 Figure 4: An aging population worldwide will put pressure on the pharmaceutical industry and overburden healthcare markets overall 6 Figure 5: Fiercely autonomous silos of R&D research and clinical development characterize most pharmaceutical companies 9 Figure 6: Technology must move towards the core of drug discovery and development 12
|
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/449913
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 29/11/2009 02:15:15 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
Translational Medicine - Drug Development Transformed? (Market Focus)
|
|
Web Address: |
http://www.researchandmarkets.com/reports/449913
|
|
Office Code: |
|
OC8HJNPOUMUXU
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic
- Single User
|
|
€1,273.00
|
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
 |
Page 2 of 2 Printed 29/11/2009 02:15:15
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder's Name: |
 |
|
|
|
Cardholder's Signature: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
 |
 |
|
|